Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer.

Macedo AVS, Hajjar LA, Lyon AR, Nascimento BR, Putzu A, Rossi L, Costa RB, Landoni G, Nogueira-Rodrigues A, Ribeiro ALP

Open source

DOI
10.1016/j.jaccao.2019.08.003
Published
2019 Sep
Container
JACC. CardioOncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jaccao.2019.08.003,
  title = {Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer.},
  author = {Macedo AVS and Hajjar LA and Lyon AR and Nascimento BR and Putzu A and Rossi L and Costa RB and Landoni G and Nogueira-Rodrigues A and Ribeiro ALP},
  year = {2019},
  journal = {JACC. CardioOncology},
  doi = {10.1016/j.jaccao.2019.08.003},
  url = {https://doi.org/10.1016/j.jaccao.2019.08.003}
}

RIS

TY  - JOUR
TI  - Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer.
AU  - Macedo AVS
AU  - Hajjar LA
AU  - Lyon AR
AU  - Nascimento BR
AU  - Putzu A
AU  - Rossi L
AU  - Costa RB
AU  - Landoni G
AU  - Nogueira-Rodrigues A
AU  - Ribeiro ALP
PY  - 2019
JO  - JACC. CardioOncology
DO  - 10.1016/j.jaccao.2019.08.003
UR  - https://doi.org/10.1016/j.jaccao.2019.08.003
ER  - 

APA

AVS, M., LA, H., AR, L., BR, N., A, P., L, R., RB, C., G, L., A, N., & ALP, R. (2019). Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer.. JACC. CardioOncology. https://doi.org/10.1016/j.jaccao.2019.08.003

Source records